Diagnostic and Prognostic Contribution of Targeted NGS in Patients With Triple‐negative Myeloproliferative Neoplasms

American Journal of Hematology - United States
doi 10.1002/ajh.25580
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Prognostic Role of Family History in Patients With Triple Negative Breast Cancer

Turk Onkoloji Dergisi
Oncology
2020English

Prognostic Value of ERBB4 Expression in Patients With Triple Negative Breast Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2016English

JAK2 Exon 14 Deletion in Patients With Chronic Myeloproliferative Neoplasms

PLoS ONE
Multidisciplinary
2010English

Circulating Endothelial Cells in Patients With Venous Thromboembolism and Myeloproliferative Neoplasms

PLoS ONE
Multidisciplinary
2013English

JAK2, CALR, and MPL Mutation Spectrum in Japanese Patients With Myeloproliferative Neoplasms

Haematologica
Hematology
2014English

Lymphoproliferative Disorders in Patients With Chronic Myeloproliferative Neoplasms: A Systematic Review

American Journal of Hematology
Hematology
2018English

High Concordance in Grading Reticulin Fibrosis and Cellularity in Patients With Myeloproliferative Neoplasms

Modern Pathology
Forensic MedicinePathology
2014English

Mutation Profiling by Targeted Sequencing of “Triple-Negative” Essential Thrombocythaemia Patients

British Journal of Haematology
Hematology
2017English

Splenectomy in Patients With Myeloproliferative Neoplasms: Efficacy, Complications and Impact on Survival and Transformation

Leukemia and Lymphoma
Cancer ResearchOncologyHematology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy